Arena Pharmaceuticals Provides Corporate Update and Reports First Quarter 2017 Financial Results

SAN DIEGO, May 9, 2017 /PRNewswire/ —¬†Arena Pharmaceuticals, Inc. (ARNA), a biopharmaceutical company focused on developing novel, small molecule drugs across multiple therapeutic areas, today provided a corporate update and reported financial results for the first quarter ended March 31, 2017.